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Abstract Previously we described the properties of a rapid
and robust yeast androgen bioassay for detection of
androgenic anabolic compounds, validated it, and showed
its added value for several practical applications. However,
biotransformation of potent steroids into inactive metabo-
lites, or vice versa, is not included in this screening assay.
Within this context, animal-friendly in-vitro cellular systems
resembling species-specific metabolism can be of value. We
thereforeinvestigated themetaboliccapacityofprecision-cut
slices of bovine liver using 17β-testosterone (T) as a model
compound, because this is an established standard com-
pound for assessing the metabolic capacity of such cellular
systems. However, this is the first time that slice metabolism
has been combined with bioactivity measurements. More-
over, this study also involves bioactivation of inactive
prohormones, for example dehydroepiandrosterone (DHEA)
and esters of T, and although medium extracts are normally
analyzed by HPLC, here the metabolites formed were
identified with more certainty by ultra-performance liquid
chromatography time-of-flight mass spectrometry (UPLC–
TOFMS) with accurate mass measurement. Metabolism of
T resulted mainly in the formation of the less potent phase
I metabolites 4-androstene-3,17-dione (4-AD), the hydroxy-
T metabolites 6α,6 β,1 5 β, and 16α-OH-T, and the phase II
metabolite T-glucuronide. As a consequence the overall
androgenic activity, as determined by the yeast androgen
bioassay, decreased. In order to address the usefulness of
bovine liver slices for activation of inactive steroids, liver
slices were exposed to DHEA and two esters of T. This
resulted in an increase of androgenic activity, because of the
formation of 4-AD and T.
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Introduction
Food and feed for humans and animals may contain residues
of contaminants. Many of these chemical residues for
example pesticides, heavy metals, and dioxins are believed
to have detrimental effects. Maximum residue limits (MRLs)
have therefore been established by the European Commis-
sion, and minimum required performance limits (MRPLs)
for forbidden substances. Regulatory authorities carry out
extensive monitoring and surveillance programs in order to
ensure consumer safety. Monitoring today is still mainly
carried out by chemical analytical methods, but bioassay
screening has been shown to be complementary and is thus a
valuable tool [1]. The main advantages of bioassay-activity-
based methods are that they are easy, cost-effective, and,
most importantly, able to detect unknown or new com-
pounds that are, consequently, absent from the chemist’s
reference set. Their main disadvantages are that they cannot
establish the identity of a compound and are often unable to
detect compounds that require metabolic activation. The
latter problem can be overcome by introduction of a
bioactivation step.
Biotransformation involves phase I and phase II path-
ways and mainly takes place in the liver and intestine [2, 3].
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DOI 10.1007/s00216-010-3605-zPhase I is usually oxidative and these reactions are mainly
catalyzed by the different enzymes of the cytochrome P450
(CYP) supergene family. In phase II, such oxidized
moieties are conjugated with highly polar molecules,
mainly glucuronic acid or sulfate. Both phases are
responsible for detoxification and rendering lipophilic
molecules more polar and more readily excreted. Several
in-vitro models are currently used to study the metabolism
of compounds. These range from simple enzyme prepara-
tions, specifically S9 fractions, microsomes, and super-
somes, to whole cell systems, for example primary cell
cultures, transformed cell lines, and tissue slices. All these
models have their specific advantages and disadvantages
and were well reviewed by Plant in 2004 and by Coecke et
al. in 2006 [4, 5]. The main advantages of whole-cell
systems is that they include the induction of drug-
metabolizing enzymes and drug transporters. However,
human-derived cell lines, for example Caco-2 and LS180,
do not express all drug-metabolizing enzymes and trans-
porters present in the small intestine and colon [6–8].
Hepatotoxicity and liver metabolism are most often studied
with freshly isolated rat hepatocytes or the human liver
HepG2 cell line. Although successful, rat hepatocytes do
not adequately predict the human in-vivo metabolism, and
gene expression patterns in human HepG2 cells strongly
depend on the manner of cultivation [9, 10]. Moreover,
during hepatocyte isolation there is a loss of cytochrome
P450 activity, which can partly be overcome by addition of
collagen or dexamethasone or by co-culture with overlay-
ing endothelial cells [11, 12]. However, there are indica-
tions that Kupffer and Ito cells in liver affect metabolism
and slow the decrease of cytochrome P450 enzyme activity
[13]. Thus, use of precision-cut liver slices has the
advantage that all liver cell types are present and maintain
their original interactions and spatial arrangement. More-
over, collagen and all phase I and phase II enzymes are
present together with natural amounts of cofactors such as
ATP, NADPH, NADP, and Mg
2+ [14]. Precision-cut liver
slices have been used successfully in a variety of studies.
Van de Bovenkamp et al. used human liver slices to study
the development of liver fibrosis and Salonen et al. studied
the metabolic clearance of selegiline, a drug used to treat
patients suffering from Parkinson disease [15–17]. Zalko et
al. and De La Torre et al. used bovine liver slices to study
the metabolism of clenbuterol and conjugated linoleic acid
(CLA), respectively [18, 19].
Here we used 17β-testosterone (T) and the prohormone
dehydroepiandrosterone (DHEA), a steroid precursor of T
that does not have hormonal activity by itself, and studied
their metabolic fate in bovine liver slices. Incubated extracts
were analyzed by ultra-performance liquid chromatography
time-of-flight mass spectrometry (UPLC–TOFMS) with
accurate mass measurement and screened for bioactivity
with a highly androgen-specific yeast bioassay. The main
objectives were to investigate whether both phase I and
phase II enzymes were active in liver cells of slices and
whether slices could thus be used as an in-vitro model to
mimic the in-vivo metabolic deactivation of T and
activation of DHEA. We also investigated whether this
deactivation and activation could be monitored with a yeast
androgen transcriptional activation assay and this latter
possibility was further explored with the inactive testoster-
one esters T-acetate and T-decanoate.
Materials and methods
Chemicals
4-Androstene-3,17-dione (4-AD), 2α,6 α,6 β,7 α,1 1 α,
11β,1 5 β, and 16α-hydroxytestosterone, and 17β-
testosterone (T) were obtained from Steraloids (Newport,
RI, USA). Testosterone glucuronide was obtained from
LGC Standards (Teddington, UK). Sodium hydrogen
carbonate, D-(+)-glucose, Titriplex III (EDTA), tris(hydrox-
ymethyl)aminomethane (Tris), calcium chloride dehydrate,
potassium chloride, sodium chloride, magnesium sulfate
heptahydrate, potassium dihydrogen phosphate, and di-
methyl sulfoxide (DMSO) were purchased from Merck
(Darmstadt, Germany). Williams’ medium E supplemented
with Glutamax I (WE) and charcoal-stripped foetal bovine
serum (csFBS) were obtained from Gibco/Invitrogen
(Breda, The Netherlands). Acetonitrile, methanol, and
diethyl ether were from Biosolve (Valkenswaard, The
Netherlands). Dextrose and yeast nitrogen base without
amino acids and without ammonium sulfate were from
Difco (Detroit, MI, USA), and dehydroepiandrosterone
(DHEA), L-Leucine, bovine serum albumin (BSA), and
HEPES were purchased from Sigma (St Louis, MO, USA).
Water used for UPLC–TOFMS was purified using a
Millipore (Bedford, MA, USA) Milli-Q system.
Preparation of liver slices
Bovine liver from male cattle (350–550 kg, 1.5–2.5 years
old) was purchased at the local slaughterhouse. Immediately
after the animals were killed the caudate liver lobe was
excised and flushed with ice-cold Krebs–Henseleit buffer
(pH 7.4) containing 10 mmol L
−1 HEPES and 25 mmol L
−1
glucose. Liver tissue was stored in ice-cold Krebs–
Henseleit buffer and transported to the laboratory within
30 min. Cylindrical cores of liver were produced using a
stainless steel tube and a drill press. Cores were immedi-
ately placed in ice-cold oxygenated Williams’ medium E
with Glutamax I (WE) supplemented with 25 mmol L
−1
glucose and 10% csFBS. A Krumdieck tissue slicer
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filled with ice-cold WE was used to produce precision-cut
slices with a diameter of 8 mm and a thickness of 0.25 mm.
Immediately after preparation, slices were stored in ice-cold
WE and only the most uniformly shaped slices were selected
for incubation experiments. Each slice weighted approxi-
mately 27 mg and contained approximately 2 mg protein.
Liver slice incubations
Bovine liver slices were incubated in six-well culture
plates. Each well contained 3.2 mL prewarmed WE
supplemented with 25 mmol L
−1 D-glucose and 10%
csFBS. Culture plates containing the liver slices were
incubated in a shaking water bath (90 rpm) under carbogen
atmosphere (95% O2 /5 %C O 2) at 37 °C. To study the
metabolizing capacity of bovine liver slices, 16 μL testos-
terone or DHEA stock solutions in DMSO were added to
WE medium (final concentration 10–250 μmol L
−1). For
each concentration incubation was performed in triplicate,
with and without slices, for 6 h. Control incubations of liver
slices were performed with 16 μL DMSO for 0, 2, 4, or 6 h.
After incubation, media were frozen and stored at −20 °C
until analysis by UPLC–TOFMS and a yeast androgen
bioassay. For ATP measurements, slices were transferred
into 1 mL sonication solution containing 70% ethanol and
2 mmol L
−1 EDTA, rapidly frozen in liquid nitrogen, and
stored at −80 °C until assayed. For histological evaluation,
slices were fixed in 4% buffered formaldehyde.
ATP measurement
To determine slice viability, ATP levels were measured as
described by De Kanter et al. in 2004 [20]. After thawing,
slices were homogenized by sonication and centrifuged at
13,000 rpm for 2 min. The supernatant was diluted 10 times
with 0.1 mol L
−1 Tris-HCl/2 mmol L
−1 EDTA solution
buffer to lower the ethanol concentration. The ATP content
was measured using a CLSII ATP bioluminescence assay
kit from Roche (Mannheim, Germany). Protein content of
liver slices were determined according to Lowry et al. [21],
using the BioRad DC protein assay (BioRad, Veenendaal,
The Netherlands) and BSA as standard. ATP determination
was performed in triplicate and results are expressed as
pmol ATP mg
−1 protein.
Histology
Immediately after incubation, slices were fixed in 4%
buffered formaldehyde. After embedding in paraffin,
cross-sections were prepared, stained with haematoxylin
and eosin using standard procedures, and examined under a
microscope [22].
Extraction procedure
Samples of medium were thawed at room temperature.
Aliquots of 3.2 mL medium were mixed with 6 mL diethyl
ether and shaken head over head for 10 min. Samples were
sonicated for 2 min in an ultrasonic bath and subsequently
centrifuged at 3,000 g for 5 min. The supernatant was
transferred to a glass tube and the residue was extracted
again with 3 mL diethyl ether. The combined organic phase
was evaporated until dryness under a gentle stream of
nitrogen gas and reconstituted in 1.5 mL acetonitrile before
screening for androgenic activity with a yeast androgen
bioassay. For HPLC analysis, samples of medium were
sometimes spiked with 10 μgm L
−1 11β-OH-T as internal
standard to generate controls and extracted with diethyl
ether as described above. The extract was evaporated under
a stream of N2 gas, reconstituted in 0.3 mL acetonitrile–
water (10:90, v/v), and 50 μL was injected into the HPLC
system. For UPLC–TOFMS analysis, 3.2 mL medium was
subjected to solid-phase extraction (SPE) on an Oasis Max
column (3 cc (60 mg) LP Extraction cartridges from Waters
Corporation, Milford, Massachusetts, USA) previously
conditioned with 6 mL methanol and 6 mL water.
Subsequently, the column was washed with 6 mL water
buffered with 2% formic acid. The column was air-dried
and eluted with 5 mL methanol. The eluate was evaporated
under a stream of N2 gas and reconstituted in 0.3 mL
acetonitrile–water (10:90, v/v), 50 μL was injected into the
UPLC–TOFMS system.
HPLC analysis
HPLC analysis was performed on a Waters HPLC System
(Waters Millipore; Milford, MA) consisting of Model 510
and 515 pumps, Model 717 plus auto injector, and an
automated gradient controller. Analytical separations were
carried out on a Symmetry C18 Column (5 μm, 3.0 ×
150 mm) at 40 °C. The mobile phases consisted of (A)
water–acetonitrile (90:10 v/v) and (B) HPLC-grade aceto-
nitrile. Gradient elution was applied at a flow rate of
1 mL min
−1, starting at 10% B and linearly programmed to
75% B in 30 min. Next, the gradient remained 5 min at
75% B and returned linearly in 5 min to the initial
conditions. The effluent was monitored at a wavelength of
247 nm with a Waters 996 photodiode-array detector. Stock
solutions of T, 4-AD, and hydroxylated testosterone stand-
ards (1 mg mL
−1) were prepared in acetonitrile and an equal
volume of each was used to prepare standard mixtures of
10 μgm L
−1. Replicate injections (n = 10) of the standard
mixtures and individual standards were analyzed to deter-
mine the variability of the retention time, peak area, and peak
height. Metabolites were determined by comparison of their
retention times using authentic standards.
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Ultra-performance liquid chromatography (UPLC) was
performed on a Waters (Milford, MA, USA) Acquity system
containing a Waters Acquity UPLC BEH C18 (1.7 μm, 2.1 ×
150 mm) column withmobilephases (A) acetonitrile–water–
formic acid (10:90:0.2, v/v) and (B) acetonitrile–water–
formic acid (90:10:0.2, v/v) at a flow rate of 0.4 mL min
−1.
After an isocratic period of 2 min at 15% B, the gradient
increased linearly to 70% B. The gradient then remained at
70% B for 2 min and was restored to the initial conditions
in 2 min. The column temperature was set at 40 °C and the
injection volume was 50 μL. Before mass spectrometry the
column effluent was split 1:1.
Mass spectrometry was performed on a Waters Micro-
mass (Manchester, UK) model LCT premier MS system
equipped with a dual electrospray ionization (ESI) probe.
The system was operated in positive-ion mode (ESI+) at a
source temperature of 120 °C, desolvation temperature
400 °C, desolvation gas flow 500 L h
−1, capillary voltage
2500 V, and a cone voltage of 50 V. Phosphoric acid in
acetonitrile–water (0.01:50:50 v/v) was used as a lock mass
calibrant and introduced via the second ESI probe at a flow
rate of 10 μLm i n
−1. Data were collected between m/z 80 and
1000 and processed using Masslynx v 4.1 software (Waters).
Androgenic activity measurement
Extracts in acetonitrile (200 μL) were transferred to a V-
shaped 96-well plate in triplicate and 50 μL of a 4% DMSO
solution was added to each well. To remove acetonitrile the
plate was dried overnight in a fume cupboard and the
remaining extract was dissolved in only 2 μLD M S Ot h en e x t
day. Aliquots of undiluted sample extracts were also investi-
gated with T spikes. These extracts spiked after extraction
were prepared by addition of 2 μL3 0μmol L
−1 Ts t o c k ,
resulting in a final concentration of 300 nmol L
−1 in the well
after adding 200 μL of the yeast culture. In the same way and
in each separate experiment a medium blank and
corresponding spikes were prepared and used as negative
and positive controls. The yeast androgenic activity mea-
surement has been described in detail before, because this
assay was fully validated according to EC guidelines, and
subsequently also accredited ISO 17025, for the determina-
tion of androgenic activity in animal feed and urine [23]. In
short: a single colony of the yeast androgen bioassay was
taken from a minimal medium agar plate with L-leucine
(MM/L) and used to inoculate 10 mL selective liquid MM/L
medium. This culture was grown overnight at 30 °C with
vigorous orbital shaking. At the late log phase, the yeast AR
cytosensor was diluted in selective MM/L medium to an OD
value at 630 nm between 0.04 and 0.06. For exposure to
standard compounds, aliquots of 200 μL of this diluted yeast
culture were pipetted into each well of a 96-well plate and
2 μL T stock solutions or other compounds in DMSO were
added. DMSO and T controls were included in each
experiment and each sample concentration was assayed in
triplicate. For exposure of yeast to sample extracts, 200 μL
aliquots of diluted yeast culture were pipetted into each well
already containing the dried extracts as described above.
Exposure was performed for 24 h at 30 °C and orbital shaking
at 125 rpm. Fluorescence and optical density (OD) were
measured at 0 and 24 h in a Synergy HT Multi-Detection
Microplate Reader (BioTek Instruments, USA) using excita-
tion at 485 nm and emission at 530 nm. The fluorescence
signal was corrected with the signals obtained with MM/L
medium containing DMSO solvent only. After incubating for
24 h, the OD at 630 nm was determined to check whether the
yeast had grown well or if a sample was toxic.
Results
ATP level
To assess the usefulness of ATP measurements as a tool to
determine the viability of slices, slices were not only
incubated with T and DHEA, but also with toxic reference
compounds. ATP levels were measured immediately after
preparation of the slices and after incubation for 2, 4 and 6 h.
Figure 1A showsthatbovineliverslicesremainedviableinthe
six-well plate incubation system for at least 6 h. However, the
ATP level was relatively low immediately after slicing and
increasedtoamaximumat4h(1.0pmolμg
−1 protein). This is
most probably because of temperature differences, as the liver
was transported on ice, sliced at low temperatures with cold
buffers, and then incubated at 37 °C. After 6 h the ATP level
in the cultured slicewasapproximately90%ofthemaximum.
The maximum ATP level obtained with the bovine liver slices
is lower than that of rat liver slices incubated under the same
conditions.The latterreached levelsof2–5p m o lμg
−1 protein
(data not shown). However, this difference may be because
of the dissimilarity of the hepatic energy status between
ruminants and rats, but could also be caused by less than
optimum conditions for the bovine liver during dissection.
The effect of addition of known toxic substances, for
examplecycloheximide(CH),sodiumazide(SA),andsodium
dodecyl sulfate (SDS), on ATP content is shown in Fig. 1B.
The ATP level was significantly reduced by 50 μgm L
−1
sodium dodecyl sulfate (170 μmol L
−1 SDS) and heating the
slices for 10 min at 75 °C. Remarkably, the ATP level was
only slightly reduced by 50 μgm L
−1 cycloheximide
(170 μmol L
−1) and sodium azide (760 μmol L
−1), but both
compounds at 5 mg mL
−1 doses significantly reduced the
ATP level. Addition of T or DHEA up to 100 μmol L
−1 did
not affect the ATP level compared with the control.
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The bovine liver slices were examined for histological
differences in order to further explore effects on viability.
Control liver slices showed normal architecture of the liver,
with a preserved trabecular structure of parenchyma cells
(Fig. 2A). The structure of slices exposed to 100 μmol L
−1
T was very similar to that of control slices. The lobular
Fig. 2 Effect of added chemicals on the histology of cultured bovine
liver slices. Haematoxylin and eosin-stained slices after 6 h of culture
with (A) 0.5% DMSO, (B) 100 μmol L
−1 T, (C)5 0μgm L
−1
cycloheximide, and (D)5 0μgm L
−1 SDS. The figures are represen-
tative of at least three separate experiments. Bars indicate a length of
20 μm. Arrows indicate necrosis of hepatocytes
Fig. 1 ATP measurements of exposed bovine liver slices. ATP levels
in bovine liver slices (A) after different incubation intervals in the
presence of 0.5% DMSO and (B) after 6 h incubation with
cycloheximide (CH), sodium azide (SA), sodium dodecyl sulfate
(SDS), 17β-testosterone (T), or DHEA. Negative controls for viability
of the slices were prepared by heating for 10 min at 75 °C. Each value
is the mean ± SEM from three to five independent experiments and
expressed as pmol ATP μg
−1 protein
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periportal triads. The nuclei with nucleoli were clearly
visible as in normal cells (Fig. 2B). Slices exposed to
100 μmol L
−1 DHEA were also very similar to the control
(data not shown).
Figure 2C shows a photomicrograph of a bovine liver
slice exposed to 50 μgm L
−1 cycloheximide. Liver
architecture was maintained with few changes, minimal
single-hepatocyte necrosis was seen (arrows), sinusoids
were slightly dilated, and most hepatocytes had a normal
appearance and the trabecular pattern was preserved. Also,
exposure to 50 μgm L
−1 sodium azide did not result in a
clear histological change (data not shown), but Fig. 2D
shows that the cell architecture was severely damaged by
50 μgm L
−1 SDS, with loss of the trabecular pattern,
reduced eosinophilic staining of the cytoplasm, and
degraded or condensed nuclei (arrows).
HPLC and UPLC–TOFMS analysis
The metabolites in extracts of medium were analyzed by
HPLC to investigate the metabolic capacity of bovine liver
slices. A set of reference compounds, based on known
metabolites and the biosynthesis of steroids, was chosen.
Van het Klooster et al., for instance, showed the formation of
2β,6 β,1 1 α,1 2 β, and 16α-OH-T when bovine hepatocyte
cultures were exposed to T [24]. Based on retention time
comparison, HPLC analysis of medium extracts obtained
from incubations of bovine liver slices with 100 μmol L
−1
T for 6 h indicated the formation of 4-AD, 6β-OH-T, and
11α-OH-T and small amounts of 2α-OH-T, 11β-OH-T,
15β-OH-T, and 16α-OH-T. From the reference set, only the
6α-OH-T could not be determined as a metabolite formed
after the slices had been exposed to T. In addition, the
HPLC profile showed a number of additional metabolites.
These results are summarized in Table 1.
UPLC–TOFMS analysis was then used to identify some
of these metabolites with more certainty. The UPLC–
TOFMS ion chromatograms are presented in Fig. 3. This
figure shows that some of the major oxidation products of T
formed could be identified as the hydroxy metabolites 6α-
OH-T, 6β-OH-T, and 15β-OH-T (Fig. 3A) and as 4-AD
and T-17-D-glucuronide (Fig. 3B). These TOFMS results
are also summarized in Table 1. In contrast with HPLC
Table 1 HPLC and UPLC–TOFMS analysis data for extracts of medium in which bovine liver slices were incubated for 6 h with testosterone
HPLC analysis UPLC-TOFMS analysis
Retention time (min)
a Possible metabolite
a Retention time (min)
b Experimental mass
c Empirical formula Identified metabolite
d
8.28 15β-OH-T I 6.27 305.2091 (−2.6) C19H29O3 15ß-OH-T
8.54 (6α-OH-T) Np II 6.35 305.2092 (−2.5) C19H29O3 6α-OH-T
9.81 6ß-OH-T III 6.74 305.2092 (−2.5) C19H29O3 6ß-OH-T
10.39 ? IV 6.98 305.2090 (−2.7) C19H29O3 ?
12.39 16α-OH-T V 7.49 305.2078 (−3.9) C19H29O3 16α-OH-T
VI 7.61 305.2131 (1.4) C19H29O3 ?
13.05 11α-OH-T 11α-OH-
T
7.83 305.2135 C19H29O3 Np
13.42 ? VII 8.10 305.2075 (−4.2) C19H29O3 ?
13.73 ?
13.94 ?
14.74 11β-OH-T VIII 8.25 305.2095 (−2.2) C19H29O3 ?
14.98 ? IX 8.29 465.2476 (−1.2) C25H37O8 T-Gluc
15.19 ?
16.25 2α-OH-T 2α-OH-T 8.9 305.2139 C19H29O3 Np
17.01 ? X 9.03 305.2080 (−3.7) C19H29O3 ?
19.20 ? XI 9.59 465.2455 (−3.3) C25H37O8 ?
20.05 17β-T XII 11.04 289.2156 (−1.2) C19H29O2 17β-T
21.18 4-AD XIII 11.79 287.2023 (1.2) C19H27O2 4-AD
Np=not present
aExperimental retention time and possible metabolite by comparison of the retention time with those of standards in HPLC
bExperimental retention times (UPLC–TOFMS)
cAccurate masses of observed ions, with mass error versus the theoretical masses in mDa (in parentheses)
dCompounds confirmed by retention time comparison with a standard (UPLC–TOFMS)
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formation of 2α-OH-T and 11α-OH-T could not be
confirmed. The formation of 11β-OH-T could not be
confirmed by TOFMS, because this compound was used
as an internal standard.
When liver slices were exposed to DHEA, the HPLC
analysisrevealedthe formationof mainly4-ADand11α-OH-T
and minor amounts of 15β-OH-T and 16α-OH-T. The for-
mation of 4-AD was confirmed by TOFMS (data not shown).
When liver slices were exposed to T or DHEA in the
presence of 50 μgm L
−1 cycloheximide, the HPLC or
TOFMS metabolite profiles were identical with that after
exposure to T or DHEA alone. Figure 3C shows the profile
of the hydroxy metabolites of T when liver slices were
exposed to T in the presence of 50 μgm L
−1 cycloheximide.
Because the metabolite profile in Fig. 3C is identical with
that of Fig. 3A, these results show that 50 μgm L
−1
cycloheximide has no effect on the metabolism of T.
Similar results were obtained with sodium azide (data not
shown).
Androgenic activity measurement
Figure 4 shows the dose–response curves of T and several
hydroxy metabolites of T in the yeast androgen bioassay;
the results are summarized in Table 2. These show that the
hydroxy metabolites of T are, relatively, much less potent
than 4-AD and T. The 2α-OH-T and 11α-OH-T are the
most potent hydroxy metabolites of T and are about 100
and 300 times less potent, respectively, than T; whereas 7α-
OH-T, 11β-OH-T, and 15β-OH-T are moderately active,
6α-OH-T and 6β-OH-T are almost inactive, and 16α-OH-T
is not active in the yeast androgen bioassay.
Medium extracts were prepared after exposure of slices
to T and DHEA and subsequently screened in the yeast
androgen bioassay. Figure 5A shows the responses of
extracts of medium in which slices were exposed to T. After
1000-fold dilution, the response of the control incubation,
i.e. without slices, is still near maximum, whereas the
response for T incubated with slices is reduced. Assuming
no metabolism and no recovery loss during the extraction
procedure, the undiluted extract and the 1000-fold diluted T
extracts would theoretically result in well concentrations of
78 μmol L
−1 and 78 nmol L
−1 T, respectively. According to
a T dose–response curve, 78 nmol L
−1 would still give a
Fig. 3 UPLC–TOFMS mass
chromatograms. UPLC–TOFMS
reconstructed accurate-mass
chromatograms for (A)
m/z 305.2117 and (B) m/z
287.2011 + m/z 289.2168+m/z
465.2488 after incubation of
bovine liver slices with
100 μmol L
−1 T for 6 h, and (C)
m/z 305.2117 after co-exposure
of liver slices to 100 μmol L
−1 T
and 50 μgm L
−1 cycloheximide
Fig. 4 Response of seven different hydroxy metabolites of T in the
yeast androgen bioassay. Exposure to 17β-testosterone (T) and
hydroxy metabolites of T was started by adding 2 μL aliquots of
stock solutions of the compound in DMSO to 200 μL yeast culture in
a 96-well plate. Fluorescence was determined after 24 h. Fluorescence
signals are means from triplicate measurements, with SD
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diluted extract of T that was incubated with liver slices,
points in the direction of metabolism of T into less
androgen-active or to androgen-inactive metabolites. This
is in agreement with the data obtained by metabolite
identification by HPLC and UPLC–TOFMS, showing that
T was metabolized into less or no active T-metabolites.
Moreover, both methods show that the capacity of these
bovine liver slices to metabolize T is relatively low,
because the drop in the androgenic response was only
observed in the 1000-fold diluted extract and, besides many
metabolites, the UPLC–TOFMS analysis still showed a
very large T peak (Fig. 3B).
The androgen assay showed no signal for a control
incubation of DHEA (100 μmol L
−1) without liver slices,
but after metabolic activation of DHEA by the bovine
slices, a maximum fluorescence response was obtained in
the yeast androgen bioassay (Fig. 5B). The signal was still
visible in the tenfold diluted extract. Because DHEA itself
does not show a response in the yeast androgen bioassay,
the signal obtained is probably because of formation of the
androgen-active metabolites 4-AD and T.
Positive controls, i.e. undiluted extracts spiked after-
w a r d sw i t hT ,r e s u l t e di naf i n a lc o n c e n t r a t i o no f
300 nmol L
−1 T in the well, which would, theoretically,
give a maximum response (black bars in Fig. 5). These
“spike-after” controls were performed in order to investi-
gate whether sample extracts contain disturbing or inhibit-
ing compounds. Figure 5B shows that only the positive
DHEA control without slices did not give a maximum
response, which means that the response of T in this extract
is inhibited. This inhibiting effect can be explained by the
antagonistic properties of DHEA, because it was demon-
strated in a previous study that DHEA is not an AR agonist,
but acts as an AR antagonist [25, 26]. Figure 5B also shows
that DHEA was activated by liver slices. Moreover, the
Table 2 EC50 concentrations and relative androgenic potencies
(RAP) of compounds in the RIKILT yeast androgen bioassay
expressing yEGFP in response to androgens
Compound EC50 (nmolL
−1)
in the RAA
a
RAP
b
17β-Testosterone (17β-T)
c 40-80
f 1.0
17α-Testosterone (17α-T)
c n.r. n.r.
5α-Dihydrotestosterone (5α-DHT)
c 33 2.3
Androsterone
c n.r. n.r.
4-Androstenedione (4-AD)
c,e 7.2E3 0.011
Dehydroepiandrosterone (DHEA)
c n.r. n.r.
2α-Hydroxytestosterone (2α-OH-T)
d 5.6E3 0.011
6α-Hydroxytestosterone (6α-OH-T)
d n.r. n.r.
6β-Hydroxytestosterone (6β-OH-T)
d n.r. n.r.
7α-Hydroxytestosterone (7α-OH-T)
d 8.6E4 7.4E-4
11α-Hydroxytestosterone (11α-OH-T)
d 2.1E4 3.0E-3
11β-Hydroxytestosterone (11β-OH-T)
d 3.0E4 2.2E-3
15β-Hydroxytestosterone (15β-OH-T)
d 1.6E5 4.0E-4
16α-Hydroxytestosterone (16α-OH-T)
d n.r. n.r.
Testosterone-17-D-glucuronide (T-Gluc)
d n.r. n.r.
17β-Estradiol (17β-E2)
c 9.0E3 8.4E-3
Progesterone
c,e 1.7E3 0.045
Dexamethasone
c n.r. n.r.
n.r. = no response.
aThe EC50 is the concentration giving half-maximum response
bThe relative androgenic potency (RAP) is defined as the ratio between the
EC50 of 17β-T and the EC50 of the compound
cObtained by Bovee et al. [35] in an experiment in which the EC50 for
17β-T was 76 nmol L
−1
dRAPs were calculated from an EC50 for 17β-T of 64 nmol L
−1
eThe maximum responses obtained with 4-androstenedione and proges-
terone, respectively, were approximately 50 and 35% of that of 17β-T
fThe range in the EC50 of 17β-T in different experiments is, in general,
between 40 and 80 nmol L
−1
Fig. 5 Androgen bioassay responses of bovine liver slices exposed to
T and DHEA. Androgen bioassay responses of (A) 100 μmol L
−1
17β-testosterone (17β-T) and (B) 100 μmol L
−1 DHEA incubated for
6 h with or without bovine liver slices. Undiluted medium extracts
were spiked with 2 μL3 0μmol L
−1 17β-testosterone in the well.
Fluorescence was determined after 24 h and signals are means from
triplicate measurements, with SD
638 S. Wang et al.antagonistic response in the positive DHEA control with
slices disappeared, once more demonstrating that DHEA
was converted into more agonistic metabolites causing a
positive response in the yeast androgen bioassay.
In addition to DHEA, two testosterone esters were
investigated in the slice model in order to further
demonstrate that slices can be used as a model to mimic
the in-vivo activation of inactive hormone precursors and
can subsequently be detected in a bioassay. According to
HPLC analysis, both T-acetate and T-decanoate were
rapidly converted into T (data not shown) and a clear
increase of androgenic activity was observed in the
bioassay. The latter is shown in Fig. 6 for T-decanoate.
Discussion
ATP content is generally regarded as a sensitive indicator of
a slice’s viability, but convincing data are limited [3]. The
usefulness of ATP measurements was more thoroughly
investigated in this study. Slices exposed to 100 μmol L
−1
T or DHEA did not affect ATP levels compared with the
control, whereas slices exposed to the toxic reference
compounds cycloheximide (CH), sodium azide (SA), and
sodium dodecyl sulfate (SDS), or heating the slices for
10 min at 75 °C, significantly reduced the ATP levels,
although relatively high concentrations of CH and SA were
needed. SA is a highly toxic substance, but its mechanism
of toxicity has not been fully established. It binds to Fe
3+ in
cytochrome oxidase in mitochondria and inhibits the
respiratory chain by cancelling oxidative phosphorylation
[27]. In a study with different human cell lines the
concentration at which sodium azide inhibited metabolic
activity, measured by a decrease in oxygen consumption,
was lower in nerve and myocardial cells than in fibroblasts,
hepatocytes, and renal tubular epithelial cells [28]. That
study showed a clear effect on oxygen consumption at
concentrations of 10 μgm L
−1 in the more sensitive nerve
and myocardial cells, whereas here there is a small effect on
the ATP level in liver cells at a dose of 50 μgm L
−1 and a
clear effect with 5 mg mL
−1. Cycloheximide is an inhibitor
of protein synthesis, and Smith et al. reported that
10 μmol L
−1 CH rapidly inhibited protein synthesis and
secretion in rat liver slices, but did not affect intracellular
K
+ and did not induce LDH leakage [29]. Thus, although
this protein synthesis inhibitor might affect the metabolic
capacity of the liver cells, especially the activity of
cytochromes P450 phase I enzymes, it is not expected that
cycloheximide in the μmol L
−1 range will induce LDH
leakage or a decrease in ATP levels. On the other hand,
many studies have shown that long-time exposure to this
concentration leads to cell death. SDS is a surfactant and is
used in cosmetic products such as soaps, shampoos, and
tooth paste. It can lead to direct damage to the hair follicle,
skin damage, permanent eye damage, and even liver
toxicity [30]. In male Wistar rats treated once a day with
25 mg SDS kg
−1 for three days, the cytochrome P-450
content of the liver was reduced by 24%, indicating that SDS
affects the metabolic capacity [31]. SDS already showed a
clear effect on the ATP level at 50 μgm L
−1. As a surfactant
SDS is also a membrane disruptor and the drop in the ATP
level of exposed liver slices was thus as expected.
The outcomes of the histological observations were all in
agreement with the assessment of the ATP content, showing
no or minimum effects with 100 μmol L
−1 T and DHEA or
low concentrations of CH and SA. Moreover, when liver
slices were exposed to T or DHEA in the presence of
50 μgm L
−1 CH or SA, the HPLC or TOFMS metabolite
profiles were identical with that obtained after exposure to
T or DHEA alone. The cell architecture was severely
damaged by 50 μgm L
−1 SDS, with loss of the trabecular
pattern, reduced eosinophilic staining of the cytoplasm, and
degraded or condensed nuclei. SDS at 50 μgm L
−1 also had
a clear effect on the ATP level. These results prove that
measurement of the ATP level is a reliable means of
assessing both the viability and metabolic capacity of liver
slice cells.
The metabolites identified, 6α-OH-T, 6β-OH-T, 15β-
OH-T, and 4-AD, after exposure of bovine liver slices to T
prove that phase I enzymes are active, and the formation of
T-17-D-glucuronide proves the activity of at least one phase
II pathway. With regard to exposure of bovine liver slices to
DHEA (in similar experiments but using slices obtained from
differentanimals),wewereabletodetectnotonly4-AD,11α-
OH-T, 15β-OH-T, and 16α-OH-T but, frequently, small
amounts of T also. The formation of both 4-AD and T is in
line with a previous study, using a bovine liver S9 mix with
NAD for metabolic bioactivation of DHEA, showing the
formation of 4-AD, T, and 7α-OH-DHEA [32].
Fig. 6 Androgen bioassay responses of bovine liver slices exposed to
T-decanoate. Androgen bioassay responses of 100 μmol L
−1 T-
decanoate incubated for 6 h with or without bovine liver slices.
Fluorescence was determined after 24 h and signals are means from
triplicate measurements, with SD
Bovine liver slices combined with an androgen transcriptional activation assay 639It has previously been shown that T is a potent
compound in the yeast androgen bioassay, whereas DHEA
is a prohormone that is not active in this bioassay [25, 32].
These studies have also shown that some phase I
metabolites, for example 4-AD, 5α-androstane-3β,17β-
diol, 5α-androstane-3αβ,17β-diol, and 5α-androstane-
17β-ol-3-one (better known as 5α-DHT), are active,
although less potent than T, in this yeast androgen bioassay,
whereas others, for example 17α-testosterone and andros-
terone, are not active. However, hydroxy metabolites of T
have not yet been tested. Here it is shown that the hydroxy
metabolites of T are, relatively, much less potent in the
yeast androgen bioassay than T and 4-AD. The 2α-OH-T
and 11α-OH-T are the most potent hydroxy metabolites of
T and are about 100 and 300 times less potent, respectively,
than T, whereas 7α-OH-T, 11β-OH-T, and 15β-OH-T are
moderately active, 6α-OH-T and 6β-OH-T are almost
inactive, and 16α-OH-T is not active.
With regard to the metabolism of the model compound T
with bovine liver slices in combination with androgen
activity measurements using the yeast bioassay, the forma-
tion of several hydroxy metabolites of T, 4-AD, and T-17-
D-glucuronide not only proves that both phase I and phase
II enzymes are active in bovine liver slices, but in line with
the formation of these less active metabolites, a clear
decrease of androgenic activity was observed. Moreover,
the conversion of the prohormone DHEA into active
metabolites like 4-AD and T resulted in a clear increase
of the androgenic activity as measured in the yeast
androgen bioassay. Also, the bioactivation of T-acetate
and T-decanoate, shown by the formation of T and an
increase of androgenic activity as determined by the yeast
bioassay, shows that bovine liver slices can be used for the
conversion of inactive prohormones and indicates that the
liver slices contain esterase activity.
In conclusion, liver slices can serve as an adequate in-
vitro model to study the species-specific metabolism of
steroids in liver and can be used as a complementary tool
for screening for biologically inactive steroids. Moreover,
application of liver slice models can reduce the use of
laboratory animals, because liver tissue can be easily
obtained from the slaughterhouse.
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